The antitumor properties of a nontoxic, nitric oxide–modified version of saquinavir are independent of AktDanijela Maksimović‐Ivanić, Ferdinando Nicoletti, Gianni Garotta et al.|Molecular Cancer Therapeutics|2009Cited by 42
In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cellsMarco Donia, Ferdinando Nicoletti, Danijela Maksimović‐Ivanić et al.|Cell Cycle|2011Cited by 40
Cytotoxic and immune-sensitizing properties of nitric oxide-modified saquinavir in iNOS-positive human melanoma cellsSanja Mijatović, Ferdinando Nicoletti, Danijela Maksimović‐Ivanić et al.|Journal of Cellular Physiology|2010Cited by 30
Therapeutic Potential of Nitric Oxide-Modified Drugs in Colon Cancer CellsMarija Mojić, Ferdinando Nicoletti, Sanja Mijatović et al.|Molecular Pharmacology|2012Cited by 29
The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6KDanijela Maksimović‐Ivanić, Sanja Mijatović, Marija Mojić et al.|Leukemia Research|2015Cited by 27